Single Ascending Dose Safety, Tolerability and Pharmacokinetics Study of GLYX-13 in Normal Volunteers
Clinical trial NCT01014650 · COMPLETED
Trial details
- NCT number
- NCT01014650
- Sponsor
- Naurex, Inc, an affiliate of Allergan plc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2015-10-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.